New progression of lobaplatin in the treatment of gynecologic cancer
10.3760/cma.j.issn.1673-422X.2014.11.015
- VernacularTitle:洛铂在妇科肿瘤治疗中的研究新进展
- Author:
Zhimin YANG
;
Yuan LIN
;
Jiayi CHEN
;
Huaying WANG
- Publication Type:Journal Article
- Keywords:
Lobaplatin;
Genital neoplasms,female;
Drug therapy
- From:
Journal of International Oncology
2014;41(11):848-851
- CountryChina
- Language:Chinese
-
Abstract:
Lobaplatin is the third generation platinum anticancer drug,and has been listed for the clinical treatment of advanced breast cancer,small cell lung cancer and chronic myeloid leukemia.Studies have shown that lobaplatin as the latest third generation platinum anticancer drug,has good water solubility,broadspectrum anti-tumor,strong anti-tumor activity,no cross-resistance with other platinum drugs,low toxicity and many other features.Lobaplatin has shown a clear advantage.
